A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell
about
Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015Telehealth interventions to reduce management complications in type 1 diabetes: A reviewCost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.Performance of a new reusable insulin penInitial experience and evaluation of reusable insulin pen devices among patients with diabetes in emerging countries.Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.Identifying and meeting the challenges of insulin therapy in type 2 diabetes.Practical aspects of insulin pen devices.Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative studyCorrect use of a new reusable insulin injection pen by patients with diabetes: a design validation study.Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionalsFactors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration.Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.Overview of insulin and non-insulin delivery devices in the treatment of diabetes.Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter studyNeedle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity.Simplicity, safety, and acceptability of insulin pen use versus the conventional vial/syringe device in patients with type 1 and type 2 diabetes mellitus in Lebanon.Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studiesA randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesDoes Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 DiabetesIntradermal insulin delivery: a promising future for diabetes management.What can we learn from patient-reported outcomes of insulin pen devices?Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens.An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen(®).Analysis of comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skillsTaste and/or Odour Disturbances in Pediatric Patients Undergoing IV Flush with Normal Saline Administered by Prefilled Syringe.Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionalsHUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab.Is the indicator magnifying window for insulin pens helpful for elderly diabetic patients?Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout studyPaediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens.Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes.
P2860
Q28082186-7110DA41-E81E-4CAC-896E-8A7EE4186584Q28085729-CF5C3E03-3F7D-4263-9F51-7A41AD8D2ED6Q30494203-0E41E431-32D6-419C-8F4F-AC03469C98F1Q30500629-6BEFE7DF-9240-41A1-B5AB-B4A871570DF4Q30609075-6FFFC875-9992-4566-8B93-3051F43E61C9Q33815567-D60A8F16-3DCC-492A-A855-A6FC614C10E7Q33863413-2D241846-C971-4C35-8F9C-50D3B2DF2B8FQ33979645-3273D484-F1D6-4281-BAB4-149C602D29D3Q34041978-2CDCBD39-6959-4EC4-8BA9-1550228E72F6Q34209154-A15F55FE-6AC4-4884-9B42-4B1010D2D9C1Q34420016-9E03A4B6-1F59-4273-992F-678CBC53743FQ34509377-71D14543-C92A-46C2-AF5D-B7A479B43F97Q34607471-DA8E097E-0A35-42EB-B0FB-D8721A82AF9DQ34620736-C872EE41-7594-4EF3-914A-1698F8E8181FQ34688748-42F8BAFA-CDA6-46F4-BE29-5DE968F053BAQ35137867-09DF9F14-4062-4AFB-A3E7-C9110A523CAFQ35154628-14879913-CA7A-44FB-92CC-A1FB57C8582AQ35248090-345EA3E3-035F-4DF3-B8F7-D19ED7243E59Q35322859-699FA4C3-1345-4999-979D-11583BF20A0FQ35529649-4A3F95EA-19EF-4895-B54A-464745859EBCQ35529658-BF17B366-77DF-4A32-AE1B-EDF90C3B6B65Q35647028-1191EF43-E866-49C6-BD12-653421203D8BQ35679023-9C5A52B1-EFA5-4B8A-83D7-83E117EF5093Q35682783-418594CF-2361-4BAE-9EA8-5D5F64F879BFQ35685005-C7615860-558C-4CC8-972D-E303822BA74AQ36015855-BB21B0B4-4BC2-426C-AD9A-9CEAC84F2EB7Q36160427-76FBF05E-4D2F-4E99-975C-22E7003F50FDQ36229341-1915BF78-BB2A-47B6-A663-0592D1A64FD3Q36337606-59C34AD6-0A74-4BF1-95C9-4E651AE95442Q36535913-E8C8A628-3C2C-4D9F-A9F0-ADD7DFFCFB83Q36758204-64E71B66-30FD-4DA2-8CA8-A448DC5A5A44Q36759489-DE465462-D303-4B8D-8995-EF3D16E3950AQ36800732-00798485-D2A9-4B44-B38E-1E02BC649A70Q36924493-D2F72D87-E707-4D72-8532-AEEB0735D60DQ36971945-D5FC3181-9DBA-4740-9D9D-0C0D3F9B4A32Q37106445-D9E3DFE0-7766-48C7-89E2-D4316F51D6C5Q37199322-F834879F-3C25-4081-8647-3516A8842F50Q37282182-DD0A2154-007C-445D-9C1D-710AACCBDBB9Q37404289-134F288C-425D-4906-A1FA-95D8F3AC3232Q37405567-6C21A42F-D629-4411-A480-8F2915F4AA79
P2860
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@en
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@nl
type
label
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@en
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@nl
prefLabel
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@en
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@nl
P2093
P921
P1476
A multicenter, randomized, ope ...... with type 1 or 2 diabetes mell
@en
P2093
Carol Jacobsen
David Bell
FlexPen Study Team
Mary Korytkowski
Rudee Suwannasari
P304
P356
10.1016/S0149-2918(03)80337-5
P577
2003-11-01T00:00:00Z